Login or Sign Up
Concord Biotech Ltd. Know Your Stock
15:58 Sep 12
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
64/100 High Financial Strength
Quality28/100 Expensive Valuation
Valuation36/100 Technically Neutral
TechnicalSWOT
Strength
7
Weakness
8
Opportunity
0
Threat
1
17.15K
Market Cap (Cr)
48.15
PE Ratio
9.46
Price to Book Ratio
43.37
RSI
30.96 %
Net Profit Margin
SWOT
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
